NCPW 2025: Fighting against Deceptive Marketing
If you’ve been misled by an ad, regulators want to hear from you. We do too.
StemGenex
A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in November 2016. The complaint alleges that the company misleadingly markets its Stem Cell Treatments will treat diseases – including Alzheimer’s, Parkinson’s, and multiple sclerosis – and 100% of its prior customers are satisfied with its service without a reasonable basis for making such claims. In addition, the complaint alleges that the company omits important information about its Stem Cell Treatments, including the dissatisfaction and complaints of ineffectiveness from customers. (Moorer et al v. StemGenex Medical Group, Inc. et al, Case No. 16-cv-2816, S. D. CA.)
The Latest
Xfinity Home Internet and Mobile Promotion
It’s easier to rack up hidden fees than it is to cancel.
AARP Membership
The only thing more “ridiculous” than the touted benefits is the cancellation process.
Should Movie Theaters Be Required to Advertise Actual Start Times?
Under a proposed bill, theaters could be fined for making moviegoers guess.
1st Phorm’s ‘110% Money-Back Guarantee’
Money-back guarantee comes up woefully short of advertised percentage.